| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.09e-06 | 4 | 17 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.02e-05 | 6 | 17 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.04e-04 | 18 | 17 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.54e-04 | 334 | 17 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.68e-04 | 129 | 17 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.67e-04 | 151 | 17 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.96e-04 | 1180 | 17 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.13e-04 | 31 | 17 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.29e-04 | 758 | 17 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.55e-04 | 33 | 17 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.05e-04 | 793 | 17 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | transporter activity | 4.77e-04 | 1289 | 17 | 6 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.17e-04 | 459 | 17 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.47e-04 | 193 | 17 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.81e-04 | 197 | 17 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | channel activity | 8.56e-04 | 525 | 17 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.62e-04 | 526 | 17 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.04e-03 | 664 | 17 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.86e-03 | 343 | 17 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.16e-03 | 749 | 17 | 4 | GO:0005509 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.20e-03 | 140 | 17 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.69e-03 | 465 | 17 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 7.05e-03 | 938 | 17 | 4 | GO:0016772 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 9.11e-03 | 171 | 17 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.51e-02 | 627 | 17 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.60e-02 | 230 | 17 | 2 | GO:0005516 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 6.84e-06 | 622 | 17 | 6 | GO:0098771 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 8.73e-06 | 1017 | 17 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.59e-05 | 1115 | 17 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 2.55e-05 | 217 | 17 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.50e-05 | 11 | 17 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 4.47e-05 | 866 | 17 | 6 | GO:0055082 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 5.78e-05 | 14 | 17 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 6.16e-05 | 1374 | 17 | 7 | GO:0006811 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 7.16e-05 | 942 | 17 | 6 | GO:0098655 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 8.97e-05 | 981 | 17 | 6 | GO:0019725 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.03e-04 | 611 | 17 | 5 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.12e-04 | 622 | 17 | 5 | GO:0006873 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.33e-04 | 21 | 17 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.80e-04 | 359 | 17 | 4 | GO:0006874 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.90e-04 | 25 | 17 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 1.90e-04 | 25 | 17 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 2.02e-04 | 705 | 17 | 5 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 2.19e-04 | 717 | 17 | 5 | GO:0050801 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 2.20e-04 | 146 | 17 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 2.23e-04 | 1157 | 17 | 6 | GO:0006812 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 2.24e-04 | 147 | 17 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 2.33e-04 | 149 | 17 | 3 | GO:0051282 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.44e-04 | 389 | 17 | 4 | GO:0055074 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.51e-04 | 392 | 17 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 2.52e-04 | 153 | 17 | 3 | GO:0051208 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.93e-04 | 161 | 17 | 3 | GO:0051592 | |
| GeneOntologyBiologicalProcess | regulation of the force of heart contraction | 3.33e-04 | 33 | 17 | 2 | GO:0002026 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 3.38e-04 | 1249 | 17 | 6 | GO:0048878 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 3.68e-04 | 174 | 17 | 3 | GO:1904064 | |
| GeneOntologyBiologicalProcess | CD8-positive, alpha-beta T cell activation | 3.96e-04 | 36 | 17 | 2 | GO:0036037 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4.19e-04 | 37 | 17 | 2 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 4.65e-04 | 39 | 17 | 2 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 4.90e-04 | 40 | 17 | 2 | GO:0071312 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 4.90e-04 | 192 | 17 | 3 | GO:0034767 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 5.93e-04 | 44 | 17 | 2 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 5.99e-04 | 493 | 17 | 4 | GO:0010959 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 6.75e-04 | 509 | 17 | 4 | GO:0006816 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 6.97e-04 | 922 | 17 | 5 | GO:0098662 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.01e-03 | 1000 | 17 | 5 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.04e-03 | 249 | 17 | 3 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 1.08e-03 | 577 | 17 | 4 | GO:0043269 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 1.17e-03 | 259 | 17 | 3 | GO:0051651 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.26e-03 | 266 | 17 | 3 | GO:0043270 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 1.36e-03 | 273 | 17 | 3 | GO:0034764 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.75e-03 | 298 | 17 | 3 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 1.94e-03 | 309 | 17 | 3 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.99e-03 | 81 | 17 | 2 | GO:0098900 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 2.20e-03 | 323 | 17 | 3 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 2.26e-03 | 326 | 17 | 3 | GO:1903522 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 2.35e-03 | 88 | 17 | 2 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.84e-03 | 97 | 17 | 2 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 2.90e-03 | 98 | 17 | 2 | GO:0051279 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 3.45e-03 | 107 | 17 | 2 | GO:0032411 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 3.48e-03 | 380 | 17 | 3 | GO:1904062 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.68e-05 | 73 | 17 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 6.04e-04 | 45 | 17 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 6.31e-04 | 46 | 17 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | cation channel complex | 8.49e-04 | 235 | 17 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.29e-03 | 88 | 17 | 2 | GO:0016529 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.30e-03 | 378 | 17 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.80e-03 | 114 | 17 | 2 | GO:0016528 | |
| Domain | RR_TM4-6 | 2.34e-06 | 3 | 17 | 2 | PF06459 | |
| Domain | Ryanrecept_TM4-6 | 2.34e-06 | 3 | 17 | 2 | IPR009460 | |
| Domain | RyR | 2.34e-06 | 3 | 17 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.34e-06 | 3 | 17 | 2 | IPR003032 | |
| Domain | Ryan_recept | 2.34e-06 | 3 | 17 | 2 | IPR013333 | |
| Domain | RIH_assoc | 1.17e-05 | 6 | 17 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.17e-05 | 6 | 17 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.17e-05 | 6 | 17 | 2 | PF08709 | |
| Domain | RYDR_ITPR | 1.17e-05 | 6 | 17 | 2 | PF01365 | |
| Domain | RIH_dom | 1.17e-05 | 6 | 17 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.17e-05 | 6 | 17 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.17e-05 | 6 | 17 | 2 | IPR015925 | |
| Domain | - | 1.17e-05 | 6 | 17 | 2 | 1.25.10.30 | |
| Domain | MIR | 3.49e-05 | 10 | 17 | 2 | PS50919 | |
| Domain | MIR | 3.49e-05 | 10 | 17 | 2 | PF02815 | |
| Domain | MIR | 3.49e-05 | 10 | 17 | 2 | SM00472 | |
| Domain | MIR_motif | 3.49e-05 | 10 | 17 | 2 | IPR016093 | |
| Domain | Ion_trans_dom | 1.41e-04 | 114 | 17 | 3 | IPR005821 | |
| Domain | Ion_trans | 1.41e-04 | 114 | 17 | 3 | PF00520 | |
| Domain | EF_HAND_2 | 1.12e-03 | 231 | 17 | 3 | PS50222 | |
| Domain | EF_hand_dom | 1.13e-03 | 232 | 17 | 3 | IPR002048 | |
| Domain | EF-hand-dom_pair | 2.08e-03 | 287 | 17 | 3 | IPR011992 | |
| Domain | SPRY | 2.79e-03 | 87 | 17 | 2 | SM00449 | |
| Domain | SPRY | 3.24e-03 | 94 | 17 | 2 | PF00622 | |
| Domain | SPRY_dom | 3.24e-03 | 94 | 17 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 3.31e-03 | 95 | 17 | 2 | IPR001870 | |
| Domain | B302_SPRY | 3.31e-03 | 95 | 17 | 2 | PS50188 | |
| Domain | EF-hand_1 | 8.26e-03 | 152 | 17 | 2 | PF00036 | |
| Domain | ConA-like_dom | 1.66e-02 | 219 | 17 | 2 | IPR013320 | |
| Domain | - | 2.30e-02 | 261 | 17 | 2 | 1.10.238.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.01e-07 | 11 | 13 | 3 | M47958 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.54e-05 | 176 | 13 | 4 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.79e-05 | 183 | 13 | 4 | M997 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 6.09e-05 | 13 | 13 | 2 | M39589 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 9.13e-05 | 99 | 13 | 3 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.12e-04 | 106 | 13 | 3 | M27200 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.33e-04 | 19 | 13 | 2 | M47760 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.94e-04 | 147 | 13 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.18e-04 | 151 | 13 | 3 | M39329 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.16e-04 | 178 | 13 | 3 | M2890 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.09e-03 | 54 | 13 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.09e-03 | 54 | 13 | 2 | M27460 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.72e-03 | 681 | 13 | 4 | MM14985 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 2.25e-07 | 2 | 17 | 2 | 21531043 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 16678258 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 8898078 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 14550562 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 14985349 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18403125 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18434746 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 6.74e-07 | 3 | 17 | 2 | 29730765 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 6.74e-07 | 3 | 17 | 2 | 9204703 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7876312 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 6.74e-07 | 3 | 17 | 2 | 12213830 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9242641 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 6.74e-07 | 3 | 17 | 2 | 10788707 | |
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 6.74e-07 | 3 | 17 | 2 | 15024040 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 6.74e-07 | 3 | 17 | 2 | 7621815 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18643873 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 6.74e-07 | 3 | 17 | 2 | 10473538 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 6.74e-07 | 3 | 17 | 2 | 4600883 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7635066 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.10e-07 | 38 | 17 | 3 | 30786075 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 18206662 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.35e-06 | 4 | 17 | 2 | 23413940 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9384575 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9607712 | ||
| Pubmed | DCIR maintains bone homeostasis by regulating IFN-γ production in T cells. | 1.35e-06 | 4 | 17 | 2 | 25926676 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23482488 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 33060591 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 2.25e-06 | 5 | 17 | 2 | 19011160 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.37e-06 | 6 | 17 | 2 | 26025922 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.37e-06 | 6 | 17 | 2 | 14592808 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.37e-06 | 6 | 17 | 2 | 25966694 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.37e-06 | 6 | 17 | 2 | 16844763 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 11860456 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.29e-06 | 8 | 17 | 2 | 19033399 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 11784029 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 23829686 | ||
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 19095005 | ||
| Pubmed | 1.05e-04 | 191 | 17 | 3 | 20195357 | ||
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 6.61e-07 | 3 | 9 | 2 | 287 | |
| GeneFamily | EF-hand domain containing | 1.40e-04 | 219 | 9 | 3 | 863 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 17 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 160 | 17 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 146 | 17 | 3 | 5b2608b56204dda9a773988f42ff00a9fa743a39 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 157 | 17 | 3 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 157 | 17 | 3 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.17e-05 | 165 | 17 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.17e-05 | 165 | 17 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.17e-05 | 165 | 17 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.35e-05 | 168 | 17 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 3.41e-05 | 169 | 17 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 169 | 17 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 3.47e-05 | 170 | 17 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 3.65e-05 | 173 | 17 | 3 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 3.71e-05 | 174 | 17 | 3 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-05 | 177 | 17 | 3 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-05 | 178 | 17 | 3 | c6704fcd21a9d2fe45679a1d998f04213b3bf224 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 4.25e-05 | 182 | 17 | 3 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 186 | 17 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.60e-05 | 187 | 17 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.83e-05 | 190 | 17 | 3 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 197 | 17 | 3 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 197 | 17 | 3 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.37e-05 | 197 | 17 | 3 | b754fad4f3caae6de95df901fd96ea8697fe41b1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.45e-05 | 198 | 17 | 3 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 51 | 17 | 2 | d43b0813f7c456f8fff77197fbbaef2f4d160563 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-04 | 68 | 17 | 2 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-MAIT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.01e-04 | 111 | 17 | 2 | 58a1536cf63568ffc985baefa495af659dd9ba88 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-03 | 128 | 17 | 2 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.10e-03 | 130 | 17 | 2 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 132 | 17 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-2|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.15e-03 | 133 | 17 | 2 | 2d9e0a29eb205a5c2c8afe2e944115ab40b22afe | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.20e-03 | 136 | 17 | 2 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 136 | 17 | 2 | b4a934feea46eeb10d407d1545bd225173078792 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-03 | 137 | 17 | 2 | 885e4cfc237eca1fa2eb1f2fd8d84f151e21ecfa | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 145 | 17 | 2 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-03 | 146 | 17 | 2 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-03 | 148 | 17 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-03 | 149 | 17 | 2 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-03 | 149 | 17 | 2 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-03 | 150 | 17 | 2 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-03 | 151 | 17 | 2 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-03 | 152 | 17 | 2 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-03 | 152 | 17 | 2 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-03 | 153 | 17 | 2 | 9f0607a88d5f8a2c128a2ff64dfbc986212f13b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-03 | 153 | 17 | 2 | 3724dd498b982be693ddff9cea7671863acf3ff8 | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-03 | 153 | 17 | 2 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-03 | 153 | 17 | 2 | d810fc5aff28449ce79b4148558b260878a2c696 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-03 | 153 | 17 | 2 | 0727dc70e16345645063c586d744bc4ac1710526 | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-03 | 153 | 17 | 2 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.51e-03 | 153 | 17 | 2 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | IIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.53e-03 | 154 | 17 | 2 | a2f51a3c5455fe2483e438375ea856afce8262fe | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.57e-03 | 156 | 17 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-03 | 156 | 17 | 2 | 095281ea78aefa0ee638191a03f8d6f62a86a9ff | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.57e-03 | 156 | 17 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-03 | 156 | 17 | 2 | 29b04143f71a0ecc600ac670abd1d521bee55fe7 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-03 | 157 | 17 | 2 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-03 | 159 | 17 | 2 | 7c2f70a7cba880115ccd676fb6c5f18488a5b74f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.63e-03 | 159 | 17 | 2 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.65e-03 | 160 | 17 | 2 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-03 | 160 | 17 | 2 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.67e-03 | 161 | 17 | 2 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.67e-03 | 161 | 17 | 2 | d0482666479530cd2fd0d229cbb59a1d79839477 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-03 | 161 | 17 | 2 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-03 | 161 | 17 | 2 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-03 | 162 | 17 | 2 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-03 | 162 | 17 | 2 | b5b2cdbcc5bbfab52cc7d8a5504d34bb2e73771a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-03 | 162 | 17 | 2 | 4f9cf67b4b00b1cf78eeb9be1c701d535021a61d | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | ASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.71e-03 | 163 | 17 | 2 | 569ca0e8ce307f258910b0c75c498009a9651e6e | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-03 | 163 | 17 | 2 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.73e-03 | 164 | 17 | 2 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-03 | 164 | 17 | 2 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-03 | 164 | 17 | 2 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-03 | 164 | 17 | 2 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-03 | 165 | 17 | 2 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-03 | 165 | 17 | 2 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | control-Plasmablast|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-03 | 165 | 17 | 2 | 61063e0ce61bc92d5d1093be8279af03f650720b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-03 | 166 | 17 | 2 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.80e-03 | 167 | 17 | 2 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-03 | 169 | 17 | 2 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 1.84e-03 | 169 | 17 | 2 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.84e-03 | 169 | 17 | 2 | ad9054ee09033b648a76baf1b2ec4a6ab1394bde | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-03 | 169 | 17 | 2 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.86e-03 | 170 | 17 | 2 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | b6882665a27c78a63f3b4a2a8806c8438a98e407 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | 626c12b9a51218f72ee32afb5fd5d4b075025d75 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-03 | 170 | 17 | 2 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | 31daac8696ae8c021c0302d3b30dd8194054b3e7 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.86e-03 | 170 | 17 | 2 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.86e-03 | 170 | 17 | 2 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-03 | 171 | 17 | 2 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-03 | 171 | 17 | 2 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| Drug | AC1MW7VF | 3.33e-07 | 19 | 17 | 3 | CID000414699 | |
| Drug | 2-hydroxyheptanoic acid | 1.57e-06 | 3 | 17 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.57e-06 | 3 | 17 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 1.57e-06 | 3 | 17 | 2 | CID000127713 | |
| Drug | 2-hydroxycarbazole | 1.57e-06 | 3 | 17 | 2 | CID000093551 | |
| Drug | aminodantrolene | 1.57e-06 | 3 | 17 | 2 | CID009570289 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.57e-06 | 3 | 17 | 2 | CID000080262 | |
| Drug | cis-diammineplatinum(II | 1.57e-06 | 3 | 17 | 2 | CID000159790 | |
| Drug | CNS 1145 | 1.86e-06 | 33 | 17 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.86e-06 | 33 | 17 | 3 | CID000162753 | |
| Drug | SC 38249 | 3.15e-06 | 4 | 17 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 3.15e-06 | 4 | 17 | 2 | CID000035682 | |
| Drug | PCB74 | 3.15e-06 | 4 | 17 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 3.15e-06 | 4 | 17 | 2 | CID006444275 | |
| Drug | Dantrolene-13C3 | 3.52e-06 | 145 | 17 | 4 | CID000002951 | |
| Drug | Dantrolene | 3.62e-06 | 41 | 17 | 3 | ctd:D003620 | |
| Drug | lindane | 4.47e-06 | 154 | 17 | 4 | CID000000727 | |
| Drug | AC1L9KQO | 6.24e-06 | 49 | 17 | 3 | CID000447335 | |
| Drug | AC1O528X | 7.86e-06 | 6 | 17 | 2 | CID006475857 | |
| Drug | NSC114784 | 7.86e-06 | 6 | 17 | 2 | CID000419425 | |
| Drug | MBED | 7.86e-06 | 6 | 17 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 7.86e-06 | 6 | 17 | 2 | CID000012008 | |
| Drug | Cinildipine | 9.35e-06 | 56 | 17 | 3 | CID000002752 | |
| Drug | Azumoleno | 1.10e-05 | 7 | 17 | 2 | CID000056259 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.10e-05 | 7 | 17 | 2 | CID009547999 | |
| Drug | Br2BAPTA | 1.10e-05 | 7 | 17 | 2 | CID003081001 | |
| Drug | nilvadipine | 1.15e-05 | 60 | 17 | 3 | CID000004494 | |
| Drug | IAA-94 | 1.21e-05 | 61 | 17 | 3 | CID000003667 | |
| Drug | lercanidipine | 1.34e-05 | 63 | 17 | 3 | CID000065866 | |
| Drug | gallopamil | 1.61e-05 | 67 | 17 | 3 | CID000001234 | |
| Drug | AC1L2AC7 | 1.76e-05 | 69 | 17 | 3 | CID000068733 | |
| Drug | CAS 298-57-7 | 2.08e-05 | 73 | 17 | 3 | CID000002761 | |
| Drug | ethosuximide | 2.17e-05 | 74 | 17 | 3 | CID000003291 | |
| Drug | Calcium | 2.33e-05 | 493 | 17 | 5 | ctd:D002118 | |
| Drug | PCB 95 | 2.35e-05 | 10 | 17 | 2 | CID000038012 | |
| Drug | nisoldipine | 2.54e-05 | 78 | 17 | 3 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.64e-05 | 79 | 17 | 3 | CID005287890 | |
| Drug | R 478 | 2.87e-05 | 11 | 17 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.87e-05 | 11 | 17 | 2 | CID003081323 | |
| Drug | PCB 66 | 2.87e-05 | 11 | 17 | 2 | CID000036185 | |
| Drug | XeC compound | 3.17e-05 | 84 | 17 | 3 | CID000005701 | |
| Drug | Ryanodine | 3.45e-05 | 12 | 17 | 2 | ctd:D012433 | |
| Drug | manidipine | 4.59e-05 | 95 | 17 | 3 | CID000004008 | |
| Drug | noradrealine | 4.86e-05 | 575 | 17 | 5 | CID000000951 | |
| Drug | isotetrandrine | 4.88e-05 | 97 | 17 | 3 | CID000005422 | |
| Drug | nitrendipine | 5.03e-05 | 98 | 17 | 3 | CID000004507 | |
| Drug | isradipine | 5.35e-05 | 100 | 17 | 3 | CID000003784 | |
| Drug | FPL 64176 | 5.48e-05 | 15 | 17 | 2 | CID000003423 | |
| Drug | Gvapspat amide | 5.48e-05 | 15 | 17 | 2 | CID000125015 | |
| Drug | AC1O3MDH | 5.67e-05 | 102 | 17 | 3 | CID006332158 | |
| Drug | loperamide | 6.18e-05 | 105 | 17 | 3 | CID000003954 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 6.80e-05 | 308 | 17 | 4 | CID000001915 | |
| Drug | kazinol B | 7.09e-05 | 17 | 17 | 2 | CID000480869 | |
| Drug | halothane | 7.33e-05 | 314 | 17 | 4 | CID000003562 | |
| Drug | methylcoumarin | 7.97e-05 | 18 | 17 | 2 | CID000007092 | |
| Drug | lamotrigine | 8.32e-05 | 116 | 17 | 3 | CID000003878 | |
| Drug | AC1NBU2S | 8.53e-05 | 117 | 17 | 3 | CID004473765 | |
| Drug | AC1L380G | 8.91e-05 | 19 | 17 | 2 | CID000084698 | |
| Drug | bepridil | 1.06e-04 | 126 | 17 | 3 | CID000002351 | |
| Drug | pimozide | 1.09e-04 | 127 | 17 | 3 | CID000016362 | |
| Drug | indo-1/AM | 1.09e-04 | 21 | 17 | 2 | CID000123918 | |
| Drug | ebselen | 1.19e-04 | 131 | 17 | 3 | CID000003194 | |
| Drug | radon | 1.32e-04 | 23 | 17 | 2 | CID000024857 | |
| Drug | lanthanum | 1.33e-04 | 136 | 17 | 3 | CID000023926 | |
| Drug | peroxynitrite | 1.42e-04 | 373 | 17 | 4 | CID000104806 | |
| Drug | zaprinast | 1.48e-04 | 141 | 17 | 3 | CID000005722 | |
| Drug | T0702 | 1.56e-04 | 25 | 17 | 2 | CID000005908 | |
| Drug | nimodipine | 1.61e-04 | 145 | 17 | 3 | CID000004497 | |
| Drug | nicardipine | 1.61e-04 | 145 | 17 | 3 | CID000004473 | |
| Drug | (2S,3R)-Sphingosine | 1.67e-04 | 389 | 17 | 4 | CID000001104 | |
| Drug | cobalt-60 | 1.69e-04 | 390 | 17 | 4 | CID000061492 | |
| Drug | Bay K 8644 | 1.78e-04 | 150 | 17 | 3 | CID000002303 | |
| Drug | aldosterone | 1.81e-04 | 397 | 17 | 4 | CID000005839 | |
| Drug | procaine | 1.89e-04 | 153 | 17 | 3 | CID000004914 | |
| Drug | Virginiamycin S1 | 1.96e-04 | 28 | 17 | 2 | CID000122731 | |
| Drug | 2,4-xylidinothiazoline | 2.25e-04 | 30 | 17 | 2 | CID000099296 | |
| Drug | LOPAC | 2.25e-04 | 30 | 17 | 2 | CID000062696 | |
| Drug | cyclophorine | 2.37e-04 | 426 | 17 | 4 | CID000002909 | |
| Drug | M-HN | 2.41e-04 | 31 | 17 | 2 | CID000015450 | |
| Drug | gabapentin | 2.53e-04 | 169 | 17 | 3 | CID000003446 | |
| Drug | felodipine | 2.53e-04 | 169 | 17 | 3 | CID000003333 | |
| Drug | M3/M4 | 2.57e-04 | 32 | 17 | 2 | CID000486507 | |
| Drug | lavendustin A | 2.62e-04 | 171 | 17 | 3 | CID000003894 | |
| Drug | riluzole | 2.76e-04 | 174 | 17 | 3 | CID000005070 | |
| Drug | papaverine | 2.85e-04 | 176 | 17 | 3 | CID000004680 | |
| Drug | AC1Q6L57 | 2.90e-04 | 34 | 17 | 2 | CID000090740 | |
| Drug | NSC7524 | 3.15e-04 | 182 | 17 | 3 | CID000005657 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 3.44e-04 | 37 | 17 | 2 | CID000009643 | |
| Drug | 4-chloro-m-cresol | 3.44e-04 | 37 | 17 | 2 | CID000001732 | |
| Drug | mag-fura-2 | 3.44e-04 | 37 | 17 | 2 | CID000123839 | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.57e-04 | 190 | 17 | 3 | 3257_UP | |
| Drug | baclofen | 3.62e-04 | 191 | 17 | 3 | CID000002284 | |
| Drug | NSC759576 | 3.62e-04 | 191 | 17 | 3 | CID000003075 | |
| Drug | AC1L98DX | 3.63e-04 | 38 | 17 | 2 | CID000439957 | |
| Drug | dihydropyridine | 3.74e-04 | 193 | 17 | 3 | CID000104822 | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 4132_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 4721_DN | |
| Drug | NAADP | 3.83e-04 | 39 | 17 | 2 | CID000123952 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 6654_DN | |
| Drug | Chrysin [480-40-0]; Up 200; 15.8uM; HL60; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 3106_UP | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.37e-07 | 3 | 17 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.37e-07 | 3 | 17 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | language measurement | 5.94e-05 | 134 | 17 | 3 | EFO_0007797 | |
| Disease | Allergic Reaction | 5.98e-04 | 63 | 17 | 2 | C1527304 | |
| Disease | Hypersensitivity | 6.17e-04 | 64 | 17 | 2 | C0020517 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 9.61e-04 | 80 | 17 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Malignant mesothelioma | 1.77e-03 | 109 | 17 | 2 | C0345967 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFNFVKAYFFLSVAA | 2201 | Q96N23 | |
| NFKLYSDAFKFIVFL | 391 | Q4VNC0 | |
| PDIFQVSYFAFKFAK | 306 | Q9NSY1 | |
| FAVIAVQLFKGKFFY | 1296 | Q00975 | |
| FVEGYFHQFFLTKKE | 31 | Q9NRE1 | |
| AFTLKVFIFQFVNFY | 586 | Q6IWH7 | |
| TAKFKDFYQFTFTFA | 151 | Q6PH85 | |
| QEIRKYFSFPVFFFK | 266 | Q6XUX3 | |
| DFTFVEVYRVKKFQF | 446 | Q8TCT0 | |
| QIVSFYFKLFKNFKD | 71 | P01579 | |
| YTVVAFNFFRKFYNK | 4781 | Q92736 | |
| FVRKFIVDYFFEEKQ | 76 | Q9HCH3 | |
| FFIAFVIFFQKYSQL | 61 | Q9UMR7 | |
| TVKRYFAKFEEKFFQ | 46 | Q9UBH6 | |
| VVAFNFFRKFYNKSE | 4686 | Q15413 | |
| LIDLYQKFGFKVFSF | 111 | Q9Y6I9 | |
| FVFDIFQFAKKFVVY | 381 | Q16222 |